Produkty 1040085-99-1

CAS 1040085-99-1 występuje w naszej ofercie pod nazwami: Budesonide EP Impurity C, Budesonide EP Impurity C (D-Homo Budesonide), Budesonide Impurity 3(Budesonide EP Impurity C), 16a,17-((1RS)-Butylidenebis(oxy))-11b-hydroxy-17-(hydroxymethyl)-D-homoandrosta-1,4-diene-3,17a-dione (Mixture of Diastereomers), 16Alpha,17-((1RS)-Butylidenebis(oxy))-11Beta-hydroxy-17-(hydroxymethyl)-D-homoandrosta-1,4-diene-3,17a-dione (Mixture of Diastereomers). Oferty producentów: Chemat Brand, Hubei YoungXin, TRC, Mikromol, GLPBio. Dostępne opakowania: on request, 10mg, 25mg, 50mg, 100mg, 200mg, 10 mg, 5 mg.

Budesonide EP Impurity C
Chemat Brand
  • opakowanie: on request
  • Warianty: 2
Zobacz produkt
Budesonide EP Impurity C (D-Homo Budesonide)
Chemat Brand
  • opakowanie: on request
  • Warianty: 1
Zobacz produkt
Budesonide Impurity 3(Budesonide EP Impurity C)
Hubei YoungXin
  • opakowanie: 10mg, 25mg, 50mg, 100mg
  • Warianty: 5
Zobacz produkt
16a,17-((1RS)-Butylidenebis(oxy))-11b-hydroxy-17-(hydroxymethyl)-D-homoandrosta-1,4-diene-3,17a-dione (Mixture of Diastereomers)
TRC
  • opakowanie: 100mg
  • Warianty: 1
Zobacz produkt
16Alpha,17-((1RS)-Butylidenebis(oxy))-11Beta-hydroxy-17-(hydroxymethyl)-D-homoandrosta-1,4-diene-3,17a-dione (Mixture of Diastereomers)
TRC
  • opakowanie: 10mg
  • Warianty: 1
Zobacz produkt
16α,17-((1RS)-Butylidenebis(oxy))-11β-hydroxy-17-(hydroxymethyl)-D-homo-androsta-1,4-diene-3,17a-dione
Mikromol
  • opakowanie: 25mg
  • Warianty: 1
Zobacz produkt
Budesonide impurity C
GLPBio
  • opakowanie: 10mg
  • Warianty: 1
od 2015,23
Zobacz produkt
(11b,16a)-16,17-(Butylidenebis(oxy))-11-hydroxy-3,20-dioxopregna-1,4-dien-21-al
Biosynth
  • opakowanie: 10mg, 25mg
  • Warianty: 2
Zobacz produkt
4aR,4bS,5S,6aS,7aR,10aR,11aS,11bS)-4b,6,6a,7a,10a,11,11a,11b,12,13-decahydro-5-hydroxy-7a-(hydroxymethyl)-4a,6a-dimethyl-9-propylflavono[2,3-d] [1,3] oxazole-2,7(4aH, 5H)-dione, 98%, 98%
Chemat
  • opakowanie: 10mg
  • Warianty: 1
od 1571,60
Zobacz produkt
Budesonide impurity C, 98.58%
MedChemExpress
  • opakowanie: 10 mg, 5 mg, 1 mg, 25 mg
  • Warianty: 4
od 598,33
Zobacz produkt
Budesonide impurity C, 98%
Fluorochem
  • opakowanie: 10mg, 100mg
  • Warianty: 2
od 2007,64
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(4aR,4bS,5S,6aS,7aR,10aR,11aS,11bS)-5-hydroxy-7a-(hydroxymethyl)-4a,6a-dimethyl-9-propyl-5,6,10a,11,11a,11b,12,13-octahydro-4bH-chryseno[2,3-d][1,3]dioxole-2,7-dione (CAS 1040085-99-1) to związek chemiczny o wzorze sumarycznym C25H34O6 i masie molowej 430.5 g/mol. Nazwa systematyczna IUPAC: (4aR,4bS,5S,6aS,7aR,10aR,11aS,11bS)-5-hydroxy-7a-(hydroxymethyl)-4a,6a-dimethyl-9-propyl-5,6,10a,11,11a,11b,12,13-octahydro-4bH-chryseno[2,3-d][1,3]dioxole-2,7-dione. InChIKey: DRLZLIQUOCVRLM-PINIVEOHSA-N.

Dane identyfikacyjne
Wzór sumarycznyC25H34O6
Masa molowa430.5 g/mol
Nazwa IUPAC(4aR,4bS,5S,6aS,7aR,10aR,11aS,11bS)-5-hydroxy-7a-(hydroxymethyl)-4a,6a-dimethyl-9-propyl-5,6,10a,11,11a,11b,12,13-octahydro-4bH-chryseno[2,3-d][1,3]dioxole-2,7-dione
InChIKeyDRLZLIQUOCVRLM-PINIVEOHSA-N
SMILESCCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@@]5([C@H]4[C@H](C[C@@]3(C(=O)[C@@]2(O1)CO)C)O)C

Dane obliczone przez PubChem (NCBI)

Synonimy: Budesonide Impurity C, Budesonide impurity C [EP], D-HOMOBUDESONIDE, BUDESONIDE IMPURITY C [EP IMPURITY], BUDESONIDE IMPURITY C (EP IMPURITY), Budesonide EP Impurity C, (11b,16a)-16,17-[Butylidenebis(oxy)]-11-hydroxy-3,20-dioxopregna-1,4-dien-21-al
Izomery (ten sam wzór sumaryczny)
[(1S,4S,5S,6R,9S,10R,12R,14R)-5,6-dihydroxy-7-(hydroxymethyl)-3,11,11,14-tetramethyl-15-oxo-4-tetracyclo[7.5.1.01,5.010,12]pentadeca-2,7-dienyl] (Z)-2-methylbut-2-enoate C25H34O6
(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one C25H34O6
(1S,2S,4R,6S,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one C25H34O6
(1S,2S,4R,6R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one C25H34O6
[(6S,8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl] propanoate C25H34O6
[2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] propanoate C25H34O6
(1S,2S,4R,8S,9S,11S,12S,13R)-6-deuterio-6-(1,1,2,2,3,3,3-heptadeuteriopropyl)-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one C25H34O6
(4R,8'S,9'S,10'R,11'S,13'S,14'S)-2-ethoxy-11'-hydroxy-2,10',13'-trimethylspiro[1,3-dioxane-4,17'-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene]-3',5-dione C25H34O6
[2-[(8'S,10'S,13'S,14'S,17'R)-17'-hydroxy-10',13'-dimethylspiro[1,3-dioxolane-2,3'-2,4,7,8,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthrene]-17'-yl]-2-oxoethyl] acetate C25H34O6
methyl (2E)-2-[(8R,9S,10R,13S,14S,17S)-2'-methoxy-2',13-dimethyl-3-oxospiro[1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-17,5'-1,3-dioxolane]-4'-ylidene]acetate C25H34O6
(1S,2S,4R,8S,9S,11S,12S,13R)-15,17,19,19-tetradeuterio-8-(2,2-dideuterio-2-hydroxyacetyl)-11-hydroxy-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one C25H34O6
[2-[(8S,9S,10R,13S,14S,17R)-3-ethoxy-17-hydroxy-10,13-dimethyl-11-oxo-2,7,8,9,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate C25H34O6